„Co my wiemy, to tylko kropelka. Czego nie wiemy, to cały ocean.”

Isaac Newton

LITERATURA NAUKOWA

Fritz Markwardt: The development of hirudin as an antithrombotic drug. Institute of Pharmacology and Toxicology, Medical Academy Erfurt, D-99012 Erfurt, Germany, Thrombosis Research, Vol 74, No. 1, pp. 1-23, 1994, Copyright 1994 Elservier Science Ltd, Printed in the USA • Dynowski Z. F.: Podstawy Hirudoterapii. Opole 2006 • Konieczny A., Zdrojewicz Z., Seifert M.: Hirudoterapia – prawda i mity. Medycyna Regeneracyjna 2/2012, 44-49 • Kapłon A., Biskup P.:Farmakoterapia przeciwzakrzepowa i fibrynolityczna- aspekty praktyczne. Studia Medyczne Akademii Świętokrzyskiej 2006, 4, 93-112 • Dunwiddie C., Thornberry N.A., Bul H.G. i wsp.: Antistasin, a leechderived inhibitor of factor Xa. Kinetic analysis of enzyme inhibition and identification of the reactive site. J. Biol. Chem. 1989, Oct, 264 (28), 16694-16699 • Knobloch K., Gohritz A., Busch K. i wsp.: Hirudo medicinalis – leech applications in plastic and reconstructive microsurgery – a literature review. Handchir. Mikrochir. Plast. Chir. 2007, Apr, 39 (2), 103-107. • Eldor A., Orevi M., Rigbi M.: The role of the leech in medical therapeutics. Blood Rev. 1996, Dec, 10 (4), 201-209. • Gronwald W., Bomke J., Maurer T. i wsp.: Structure of the leech protein saratin and characterization of its binding to collagen. J. Mol. Biol. 2008, Sep 12, 381 (4), 913-927 • Kose A., Zenqin S., Kose B. i wsp.: Leech bites: massive bleeding, coagulation profile disorders, and severe anemia. Am. J. Emerq. Med. 2008, Nov, 26 (9), 1067, e 3-6. • Baskova I.P., Zavalova L.L.: Polyfunctionality of destabilase, a lysozyme from a medicinal leech. Bioorg. Khim. 2008, May-Jun, 34 (3), 337-343 • Chalisova N.I., Baskova I.P., Zavalova L.L. i wsp.: Neurite-stimulating effect of Hirudo medicinalis salivary gland secreting factors in organotypic culture of the dorsal root ganglia. Ross. Fiziol. Im. I. M. Sechenova. 2001, Jun, 87 (6), 815-820 • Chalisova N.I., Baskova L.P., Zavalova L.L. i wsp.: The neurite-stimulating influence of components of medicinal leech salivary gland secretions in organotypic culture of spinal ganglia. Neuroscience and behavioral physiology. 2003, 33, (1), 85-88, 2003. • Budzynski A.Z.: Interaction of hementin with fibrinogen and fibrin, Blood Coagul Fibrinolysis. 1991, Feb, 2 (1), 149-152. • Chudzinski-Tavassi A.M., Kelen E.M., de Paula Rosa A.P. i wsp.: Fibrino( geno)lytic properties of purified hementerin, a metalloproteinase from the leech Haementeria depressa. Thromb. Haemost. 1998, Jul, 80 (1), 155-160 • Nikonov G.I., Titova E.A., Seleznev K.G.: A stable prostacyclin-like substancje produced by the medicinal leech Hirudo medicinalis. Prostaglandins Other Lipid Mediat. 1999, Aug, 58 (1), 1-7 • Baskova I.P.., Iusupova G.I., Nikonov G.I.: Lipase and cholesterol-esterase activity in the salivary gland secretions of the medical leech Hirudo medicinalis. Biokhimiia. 1984, Apr, 49 (4), 676-678 • Sviridkina L.P., Borovaia E.P., Makhneva A.V.: Hirudotherapy in combined sanatorium-spa treatment of patients with coronary heart disease. Vopr Kurortol. Fizioter. Leech. Fiz. Kult. 2008, May-Jun, (3), 12-15 • Baskova I.P., Zavalova L.: Proteinase inhibitors from the medicinal leech Hirudo medicinalis. Biochemistry (Moscow). 2001, 66, 7, 703- 714 (12) • Salgueiro S., Potts S., McIlgorm E.A. i wsp.: A protein from the salivary glands of the giant Amazon leech with high sequence homology to a nicotinic acetylcholine receptor subunit. Z. Naturforsch. [C]. 1999, Nov, 54 (11), 963-71. • Laufer A.S., Siddall M.E., Graf J.: Characterization of the digestivetract microbiota of Hirudo orientalis, a european medicinal leech. Appl. Environ. Microbiol. 2008, Oct, 74 (19), 6151-6154. • Hovinqh P., Linker A.: Hyaluronidase activity in leeches (Hirudinea). Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 1999, Nov, 124 (3), 319-326. • Tarnowska R., Car H.: Hirudoterapia - za i przeciw. Farmacja Polska 2009, 65( 5), 331-337 • A. Michalsen, S. Klotz, Rainer Lüdtke, S. Moebus, G. Spahn, G. J. Dobos: Effectiveness of Leech Therapy in Osteoarthritis of the Knee A Randomized, Controlled Trial; Annals of Internal Medicine, 4 November 2003, Volume 139, Number 9, 724-730

Wymienione poniżej publikacje stanowią jedynie fragment obecnej wiedzy o leczeniu pijawkami ludzi. Wybrane zostały pozycje mogące lepiej uzmysłowić zakres wiedzy, która stanowi zaledwie fundament do dalszych badań.

PRZECZYTAJ

Hirudoterapia - prawda i mity
Effectiveness of Leech Therapy in Osteoarthritis of the Knee A Randomized, Controlled Trial
Hirudoterapia - za i przeciw
Hirudoterapia - prawda i mity
A. Konieczny, Z. Zdrojewicz, M. Seifert; Medycyna Regeneracyjna 2/2012, 44-49
Effectiveness of Leech Therapy in Osteoarthritis of the Knee A Randomized, Controlled Trial
A. Michalsen, S. Klotz, Rainer Lüdtke, S. Moebus, G. Spahn, G. J. Dobos; Ann Intern Med. 2003; 139:724-730.
Hirudoterapia - za i przeciw
R. Tarnowska, H. Car; Farm Pol, 2009, 65(5): 331-337

Więcej literatury

Przy poszczególnych pozycjach podano również źródła internetowe gdzie publikację można znaleźć

Markwardt, F. Untersuchungen über Hirudin. Naturwissenschaften. 1955;42:537–538. Crossref | Scopus (54) | Google Scholar • Markwardt, F. Die antagonistische Wirkung des Hirudins gegen Thrombin in vivo. Naturwissenschaften. 1956;43:111–112. Crossref | Scopus (10) | Google Scholar • Markwardt, F. Untersuchungen über den Mechanismus der blutgerinnungshemmenden Wirkung des Hirudins. Naunyn Schmiedeberg's Arch Exp Pathol Pharmacol. 1956;229:389–399. Crossref | PubMed | Scopus (26) | Google Scholar • Markwardt, F. Die Isolierung und chemische Charakterisierung des Hirudins. Hoppe Seylers Z Physiol Chem. 1957;308:147–156. Crossref | PubMed | Scopus (11) | Google Scholar • Markwardt, F. Versuche zur pharmakologischen Charakterisierung des Hirudins. Naunyn Schmiedeberg's Arch Exp Pathol Pharmacol. 1958;234:516–529. PubMed | Google Scholar • Markwardt, F., Walsmann, P. Die Reaktion zwischen Hirudin und Thrombin. Hoppe Seylers Z Physiol Chem. 1958;312:85–98. Crossref | PubMed | Scopus (44) | Google Scholar • Markwardt, F. Über den Einflußzlig; des Hirudins auf die Thrombin-bildung. Naunyn Schmiedeberg's Arch Exp Pathol Pharmacol. 1959;236:286. Google Scholar • Markwardt, F. Hirudin, der blutgerinnungshemmende Wirkstoff des medizinischen Blutegels. Blut. 1958;4:161–170. Crossref | Scopus (4) | Google Scholar • Markwardt, F. Die Bestimmung des Thrombins durch Titration mit Hirudin. Arch Pharmazie. 1957;290:280–284. Crossref | Scopus (1) | Google Scholar • Markwardt, F. Die quantitative Bestimmung des Prothrombins durch Titration mit Hirudin. Naunyn Schmiedeberg's Arch Exp Pathol Pharmacol. 1958;232:487–498. • Crossref | PubMed | Scopus (4) | Google Scholar • Markwardt, F. Der Hirudintoleranztest. Klin Wochenschr. 1959;37:1142–1143. Crossref | PubMed | Scopus (3) | Google Scholar • Schmutzler, R., Markwardt, F. Der Hirudintest, eine Mikromethode zur Kontrolle des Prothrom Prothrombinspiegels bei der Antikoagulantientherapie. Klin Wochenschr. 1962;40:796–798. • Crossref | PubMed | Scopus (4) | Google Scholar • Markwardt, F., Wenzel, G. Die Anwendung der Prothrombinbe-stimmung mit Hirudin zur überwachung der Behandlung mit Dicumarolderivaten. Blut. 1961;7:37–40. Crossref | PubMed | Scopus (2) | Google Scholar • Jutisz, M., Charbonnel-Berault, A., Marinoli, G. Purification de l'hirudine. Bull Soc Chim Biol. 1963;45:55–67. PubMed | Google Scholar • Markwardt, F., Schäfer, G., Töpfer, H., Walsmann, P. Die Isolierung des Hirudins aus medizinischen Blutegeln. Pharmazie. 1967;22:239–241. Google Scholar • Markwardt, F., Walsmann, P. Reindarstellung und Analyse des ThrombinInhibitors Hirudin. Hoppe Seylers Z Physiol Chem. 1967;348:1381–1386. Crossref | PubMed | Scopus (50) | Google Scholar • Bagdy, D., Barabas, E., Graf, L. Large scale preparation of hirudin. Thromb Res. 1973;2:229–232. Abstract | Full Text PDF | Scopus (21) | Google Scholar • Walsmann, P., Markwardt, F. On the isolation of the thrombin inhibitor hirudin. Thromb Res. 1985;40:563–570. Abstract | Full Text PDF | PubMed | Scopus (26) | Google Scholar • Markwardt, F. Hirudin as an inhibitor of thrombin. in: Methods in Enzymology. Vol. XIX. Academic Press, New York; 1970:924–932 (Proteolytic Enzymes). Google Scholar • Petersen, T.E., Roberts, H.R., Sotrup-Jensen, L., Magnusson, S. Primary structure of hirudin, a thrombin-specific inhibitor. in: H. Peeters (Ed.) Protides of the Biologic Fluids. Pergamon Press, Oxford; 1976:145–149. Google Scholar • Markwardt, F., Hauptmann, J., Nowak, G., Klessen, C., Walsmann, P. Pharmacological studies on the antithrombotic action of hirudin in experimental animals. Thromb Haemost. 1982;47:226–229. • PubMed | Google Scholar • Markwardt, F., Hoffmann, A., Stürzebecher, J. Influence of thrombin inhibitors on the thrombin-induced activation of human blood platelets. Haemostasis. 1983;13:227–233. PubMed | Google Scholar • Ishikawa, A., Hafter, R., Seemüller, U., Gokel, J.M., Graeff, H. The effect of hirudin on endotoxin induced disseminated intravascular coagulation (DIC). Thromb Res. 1980;19:351–358. Abstract | Full Text PDF | PubMed | Scopus (17) | Google Scholar • Markwardt, F., Nowak, G., Stürzebecher, J., Griessbach, U., Walsmann, P., Vogel, G. Pharmacokinetics and anticoagulant effect of hirudin in man. Thromb Haemost. 1984;52:160–163. PubMed | Google Scholar • Nowak, G., Markwardt, F. Influence of hirudin on endotoxin-induced disseminated intravascular coagulation (DIC) in weaned pigs. Exp Pathol. 1980;18:438–443. Google Scholar • Markwardt, F., Nowak, G., Hoffmann, J. Comparative studies on thrombin inhibitors in experimental microthrombosis. Thromb. Haemost. 1983;49:235–237. PubMed | Google Scholar • Bichler, J., Fichtl, B., Siebeck, M., Fritz, H. Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration. Arzneimittelforschung. 1988;38:704–710. PubMed | Google Scholar • Dodt, J., Müller, H.P., Seemüller, U., Chang, J.Y. The complete amino acid sequence of hirudin, a thrombin specific inhibitor. FEBS Lett. 1984;165:180–183. Crossref | Scopus (140) | Google Scholar • Dodt, J., Seemüller, U., Maschler, R., Fritz, H. The complete covalent structure of hirudin. in: Localization of the disulfide bonds. Biol Chem Hoppe Seyler. 366. ; 1985:379–385. Google Scholar • Dodt, J., MacHleidt, W., Seemüller, U., Maschler, R., Fritz, H. Isolation and characterization of hirudin isoinhibitors and sequence analysis of hirudin PA. Biol Chem Hoppe Seyler. 1986;367:803–811. Crossref | PubMed | Scopus (67) | Google Scholar • Tripier, D. Hirudin: A family of iso-proteins isolation and sequence determination of new hirudins. Folia Haematol. 1988;115:30–35. Google Scholar • Scharf, M., Engels, J., Tripier, D. Primary structures of new iso-hirudins'. FEBS Lett. 1989;225:105–110. Crossref | Scopus (68) | Google Scholar • Stone, S.R., Hofsteenge, J. Kinetics of the inhibition of thrombin by hirudin. Biochemistry. 1986;25:4622–4628. Crossref | PubMed | Scopus (477) | Google Scholar • Konno, S., Fenton, J.W II, Villanueva, G.B. Analysis of the secondary structure of hirudin and the mechanism of its interaction with thrombin. Arch Biochem Biophys. 1988;267:158–166. • Crossref | PubMed | Scopus (42) | Google Scholar • Rydel, T.J., Tulinsky, A., Bode, W., Huber, R. Refined structure of the hirudin-thrombin complex. J Mol biol. 1991;20:583–601. Crossref | Scopus (292) | Google Scholar • Rydel, T.J., Ravichandran, K.Q., Tulinsky, A., Bode, W., Huber, R., Roitsch, C., Fenton, J.W. II. The structure of a complex of recombinant hirudin and human-thrombin. Science. 1990;249:277–280. Crossref | PubMed | Scopus (586) | Google Scholar • Harvey, R.P., Degryse, E., Stefani, L., Schamber, F., Cazenave, J.P., Courtney, M., Tolstshev, P., Lecocq, J.P. Cloning and expression of cDNA coding for the anticoagulant hirudin from the blood sucking leech. (Hirudo medicinalis)in: Proc Natl Acad Sci USA. 83. ; 1986:1084–1088. Google Scholar • Bergmann, C., Dodt, J., Köhler, S., Fink, E., Gassen, H.G. Chemical synthesis and expression of a gene coding for hirudin, the thrombin-specific inhibitor from the leech Hirudo medicinalis. Biol Chem Hoppe Seyler. 1986;367:731–740. Crossref | PubMed | Scopus (71) | Google Scholar • Grossenbacher, H., Auden, J.A.L., Bill, K., Liersch, M., Märki, W.E., Maschler, R. Isolation and characterization of recombinant desulfatohirudin from yeast, a highly selective thrombin inhibitor. Thromb Res. 1987;7:34. Abstract | Full Text PDF | Google Scholar • Markwardt, F., Fink, E., Kaiser, B., Klöcking, H.-P., Nowak, G., Richter, M., Stürzebecher, J. Pharmacological survey of recombinant hirudin. Pharmazie. 1988;43:202–207. PubMed | Google Scholar • Markwardt, F., Nowak, G., Stürzebecher, J., Griessbach, U., Walsmann, P., Vogel, G. Clinico-pharmacological studies with recombinant hirudin. Thromb Res. 1988;52:393–400. Abstract | Full Text PDF | PubMed | Scopus (60) | Google Scholar • Markwardt, F., Nowak, G., Stürzebecher, U., Walsmann, P. Studies on the pharmacokinetics of hirudin. Biomed Biochim Acta. 1987;46:237–244. • PubMed | Google Scholar • Markwardt, F., Kaiser, B., Nowak, G. Studies on antithrombotic effects of recombinant hirudin. Thromb Res. 1989;54:377–388. Abstract | Full Text PDF | PubMed | Scopus (59) | Google Scholar • Vogel, G., Markwardt, F. Preliminary clinical reports on the antithrombotic action of hirudin. Thromb Res (Suppl.). 1987;7:42. Abstract | Full Text PDF | Google Scholar • Parent, F., Dreyfus, M., Musset, D., Grimon, G., Duroux, P., Meyer, D., Simonneau, G. Treatment of severe venous thrombo-embolism with intravenous hirudin (HBW 023): An open pilot study. Thromb Haemost. 1993;70:386–388. PubMed | Google Scholar • Meyer, B.H., Luus, H.G., Müller, F.O., Badenhorst, P.N., Röthig, H.J. The pharmacology of recombinant hirudin, a new anticoagulant. South Afr Med J. 1990;78:268–270. PubMed | Google Scholar • Markwardt, F., Nowak, G., Stürzebecher, J. Clinical pharmacology of recombinant hirudin. Haemostasis. 1991;21:133–136. PubMed | Google Scholar • Glusa, E., Schenk, J., Breddin, K., Butti, A., Markwardt, F. Studies in human pharmacology of recombinant hirudin. Thromb Res. 1992;65:118. Abstract | Full Text PDF | Google Scholar • NURMOHAMED, M.T., KNIPSCHEER, H.C., BULLER, H.R. and CATE, J.W. An open study to investigate the biological efficacy of repeated subcutaneous applications of r-hirudin (CGP 39393) in healthy volunteers. Thromb Haemost 65, 650, 191.. Google Scholar • Markwardt, F. Hirudin als potentielles Antikoagulans zur Prävention der Rethrombosierung nach intrakoronarer Lyse und Angioplastie. Hämostaseologie. 1989;9:204–208. Google Scholar • Markwardt, F. Prospective clinical use of hirudin as an anticoagulant. Biomed. Prog. 1990;3:19–23. Google Scholar • Bagdy, D., Barabas, E., Graf, L., Peterson, T.E., Magnusson, S. Hirudin. Methods Enzymol. 1976;45:669–678. PubMed | Google Scholar • Markwardt, F. Pharmacology of hirudin: One hundred years after the first report of the anticoagulant agent. Biomed Biochim Acta. 1985;44:1007–1013. PubMed | Google Scholar • Markwardt, F. Biochemistry and pharmacology of hirudin. in: H. Pirkle, F.S. Markland Jr. (Eds.) Hemostasis and Animal Venoms. Dekker, New York; 1988:255–269. Google Scholar • Markwardt, F. The comeback of hirudin-An old-established anticoagulant agent. Folia Haematol (Lpz). 1988;115:10–23. Google Scholar • Markwardt, F. Development of hirudin as an antithrombotic agent. Semin Thromb Hemost. 1989;15:269–282. Crossref | PubMed | Scopus (96) | Google Scholar • Markwardt, F. Past, present and future of hirudin. Haemostasis. 1991;21:11–26. PubMed | Google Scholar • Hoet, B., Close, P., Vermylen, M., Verstraete, M. Hirudo medicinalis and hirudin. in: Recent Advances in Blood Coagulation. Vol. 3. Churchill Livingstone, London; 1990:223–244. Google Scholar • Markwardt, F. Hirudin and derivatives as anticoagulant agents. Thrombos Haemostas. 1991;66:141–152. PubMed | Google Scholar • Markwardt, F. The development of hirudin as an anticoagulant agent. Curr Cardiovasc Patents. 1991;1:981–995. Google Scholar • Markwardt, F. Hirudin: The promising antithrombotic. Cardiovasc Drug Rev. 1992;10:211–232. Crossref | Scopus (43) | Google Scholar • Müller-Berghaus, G., Riess, F.C., Pötzsch, B., Nowak, G. Hirudin update. in: G.G. Neri Serneri, D. Prisco, G.F. Gensini, R. Abbate (Eds.) Thrombosis an Update. Scientific Press, Florence; 1992:133–147. Google Scholar • Märki, W.E., Grossenbacher, H., Grütter, M.G., Liersch, M.H., Meyhack, B., Heim, J. Recombinant hirudin: Genetic engineering and structure analysis. Semin Thromb Hemost. 1991;17:88–93. Crossref | PubMed | Scopus (29) | Google Scholar • Fareed, J., Walenga, J.M., Hoppensteadt, D., Pifarre, R. Development perspectives for recombinant hirudin as an anti-thrombotic agent. Biol Clin Hematol. 1989;11:143–152. Google Scholar • Walenga, J.M., Pifarre, R., Fareed, J. Recombinant hirudin as antithrombotic agent. Drugs Future. 1990;15:267–280. Google Scholar • Stürzebecher, J., Walsmann, P. Structure-activity relationships of recombinant hirudins. Semin Thromb Hemost. 1991;17:94–98. Crossref | PubMed | Scopus (8) | Google Scholar • Johnson, P.H., Sze, P., Winant, R., Payne, P.W., Lazur, J.B. Biochemistry and genetic engineering of hirudin. Sem Thromb Hemost. 1989;15:302–315. Crossref | PubMed | Scopus (38) | Google Scholar • Lindhout, T., Blezer, R., Hemker, H.C. The anticoagulant mechanism of action of recombinant hirudin (39393) in plasma. Thromb Haemost. 1990;64:464–468 (138). PubMed | Google Scholar • Ofuso, F.A., Fenton, J.W. II, Maraganore, J., Blajchman, M.A., Yang, X., Smith, L., Asnvari, N., Buchanan, M.R., Hirsh, J. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin. Biochem J. 1992;283:893–897. Crossref | PubMed | Scopus (25) | Google Scholar • Hauptmann, J., Brüggener, E., Markwardt, F. Effect of heparin, hirudin and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats. Hemostasis. 1987;17:321–328. PubMed | Google Scholar • Walsmann, P., Markwardt, F. Biochemische und pharmakologische Aspekte des Thrombininhibitors Hirudin. Pharmazie. 1981;36:653–660. PubMed | Google Scholar • Glusa, E., Markwardt, F. Platelet functions in recombinant hirudin-anticoagulated blood. Hemostasis. 1990;20:112–118. PubMed | Google Scholar • Glusa, E. Hirudin and platelets. Semin Thromb Hemost. 1991;17:122–125. Crossref | PubMed | Scopus (23) | Google Scholar • Glusa, E., Markwardt, F. Adrenaline-induced reactions of human platelets in hirudin plasma. Hemostasis. 1980;9:188–192. PubMed | Google Scholar • Markwardt, F., Stürzebecher, J., Glusa, E. Antithrombin effects of native and recombinant hirudins. Biomed Biochim Acta. 1990;49:399–404. PubMed | Google Scholar • Glusa, E., Markwardt, F. Studies on thrombin-induced endothelium-dependent vascular effects. Biomed Biochim Acta. 1988;47:623–630. PubMed | Google Scholar • Markwardt, F. Pharmacological approaches to thrombin regulation. Ann NY Acad Sci. 1986;485:204–214. Crossref | PubMed | Scopus (17) | Google Scholar • Obberghen-Schilling, E., van Perez-Rodriguez, R., Pouyssegur, J. Hirudin, a probe to analyze the growth promoting activity of thrombin in fibroblasts; Reevaluation of the temporal action of competence factors. Biochem Biophys Res Commun. 1982;105:79–86. Crossref | Scopus (27) | Google Scholar • Klöcking, H.-P., Hoffmann, A., Markwardt, F. Influence of hirudin on the thrombin-induced release of tissue plasminogen activator from isolated perfused pig ear. Folia Haematol. 1988;115:110–120. Google Scholar • Markwardt, F. Jr., Franke, T., Glusa, E., Nilius, B. Pharmacological modification of mechanical and electrical responses of frog heart to thrombin. Naunyn Schmiedeberg's Arch Pharmacol. 1990;341:341–346. Crossref | PubMed | Scopus (8) | Google Scholar • Walsmann, P. Über den Einsatz des spezifischen Thrombin-Inhibitors Hirudin für diagnostische und biochemische Untersuchungen. Pharmazie. 1988;43:737–744. PubMed | Google Scholar • Markwardt, F. Hirudin-Biochemisch-pharmakologische Wirkung und Anwendung zur gerinnungsphysiologischen Diagnostik. in: R. Marx, H.A. Thies (Eds.) Kontrolle von Antithrombotika. Editiones Roche, Basel; 1980:105–115. Google Scholar • Stocker, K. Laboratory use of hirudin. Semin Thromb Hemost. 1991;17:113–121. Crossref | PubMed | Scopus (8) | Google Scholar • Zoldhelyi, P., Chesebro, J.H., Owen, W.G. Hirudin as a molecular probe for thrombin in vitro and during systemic coagulation in the pig. in: Proc Natl Acad Sci USA. 90. ; 1993:1819–1823. Google Scholar • Griessbach, U., Stürzebecher, J., Markwardt, F. Assay of hirudin in plasma using a chromogenic thrombin substrate. Thromb Res. 1985;37:347–350. Abstract | Full Text PDF | PubMed | Scopus (60) | Google Scholar • Markwardt, F., Stürzebecher, J., Walsmann, P. The hirudin standard. Thromb Res. 1990;59:395–400. • Abstract | Full Text PDF | PubMed | Scopus (9) | Google Scholar • Stürzebecher, J. Methods for determination of hirudin. Semin Thromb Hemost. 1991;17:99–102. Crossref | PubMed | Scopus (8) | Google Scholar • Stürzebecher, J., Markwardt, F., Wagner, G., Voigt, B. Are synthetic inhibitors able to improve factor Xa assays using peptide substrates?. Thromb Res. 1982;26:221–226. Abstract | Full Text PDF | PubMed | Scopus (4) | Google Scholar • Markwardt, F., Kaiser, B., Richter, M. Haemostyptic effects of batroxobin with regard to hirudin treatment. Thromb Res. 1992;68:475–482. Abstract | Full Text PDF | PubMed | Scopus (8) | Google Scholar • Walenga, J.M., Hoppensteadt, D., Koza, M., Pifarre, R., Fareed, J. Comparative studies on various assays for the laboratory evaluation of r-hirudin. Semin Thromb Hemost. 1991;17:103–112. Crossref | PubMed | Scopus (20) | Google Scholar • Klöcking, H.-P., Güttner, J., Fink, E., Markwardt, F. Studies in toxicity of recombinant hirudin. Blut. 1990;60:129. Google Scholar • Klöcking, H.-P. Toxicology of hirudin. Sem Thromb Hemost. 1991;17:126–129. Crossref | PubMed | Scopus (6) | Google Scholar • Bichler, J., Gemmerli, R., Fritz, H. Studies for revealing a possible sensitization to hirudin after repeated intravenous injection in baboons. Thromb Res. 1991;61:39–51. Abstract | Full Text PDF | PubMed | Scopus (22) | Google Scholar • Richter, M., Cyranka, U., Nowak, G., Walsmann, P. Pharmacokinetics of 125I-hirudin in rats and dogs. Folia Haematol. 1988;115:64–69. Google Scholar • Markwardt, F., Huan, X.Q., Walenga, J.M., Münch, M., Hoppensteadt, D. Pharmacokinetics of recombinant hirudin in primates (abstract). Fed Proc. 1988;1:484. Google Scholar • Henschen, A., Markwardt, F., Walsmann, P. Evidence for the identity of hirudin isolated after kidney passage with the starting material. Folia Haematol. 1988;115:59–63. Google Scholar • Nowak, G., Markwardt, F., Fink, E. Pharmacokinetic studies with recombinant hirudin in dogs. Folia Haematol. 1988;115:70–74. Google Scholar • Nowak, G. Pharmacokinetics of hirudin. Semin Thromb Hemost. 1991;17:145–149. Crossref | PubMed | Scopus (17) | Google Scholar • Iyer, L., Koza, M., Iqbal, O., Calabria, R., Fareed, J. Studies on the pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after intravenous and subcutaneous administration in dogs. Thromb Res. 1993;69:259–269. Abstract | Full Text PDF | PubMed | Scopus (9) | Google Scholar • Iyer, L., Shavit, J., Koza, M., Calabria, R., Moran, S., Fareed, J. Alteration of pharmacokinetics and pharmaco-dynamics of recombinant hirudin (rHV2-Lys 47) after repeated intravenous administration in dogs. Thromb Res. 1993;69:59–70. Abstract | Full Text PDF | PubMed | Scopus (10) | Google Scholar • Richter, M., Walsmann, P., Markwardt, F. Plasma level of dextran-r-hirudin. Pharmazie. 1989;44:73–74. PubMed | Google Scholar • Markwardt, F., Richter, M., Walsmann, P., Riesener, G., Paintz, M. Preparation of dextran-bound recombinant hirudin and its pharmacokinetic behaviour. Biomed Biochim Acta. 1990;49:1103–1108. PubMed | Google Scholar • Ito, R., Phaneauf, M.D., Logerfo, F.W. Thrombin inhibition by covalently bound hirudin. Blood Coag Fibrinol. 1991;2:77–81. Crossref | PubMed | Google Scholar • Rübsamen, K., Eschenfelder, V. Reocclusion after thrombolysis: A problem solved by hirudin. Blood Coag Fibrinol. 1991;2:97–100. Crossref | PubMed | Scopus (9) | Google Scholar • Kaiser, B., Markwardt, F. Antithrombotic and haemorrhagic effects of synthetic and naturally occurring thrombin inhibitors. Thromb Res. 1986;43:613–620. Abstract | Full Text PDF | PubMed | Scopus (35) | Google Scholar • Agnelli, G., Pascucci, C., Cosmi, B., Nenci, G.G. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits. Thromb Haemost. 1990;63:204–207. PubMed | Google Scholar • Krupinski, K., Breddin, H.K., Markwardt, F., Haarmann, W. Antithrombotic effects of three thrombin inhibitors in a rat model of laser-induced thrombosis. Haemostasis. 1989;19:74–82. PubMed | Google Scholar • Doutremepuich, C., Deharo, E., Guyot, M., Lalanne, M.C., Walenga, J.M., Fareed, J. Antithrombotic activity of recombinant hirudin in the rat: A comparative study with heparin. Thromb Res. 1989;54:435–445. Abstract | Full Text PDF | PubMed | Scopus (18) | Google Scholar • Kaiser, B. Anticoagulant and antithrombotic actions of recombinant hirudin. Semin Thromb Hemost. 1991;17:130–136. • Crossref | PubMed | Scopus (19) | Google Scholar • Talbot, M.D., Ambler, J., Butler, K.D., Findley, V.S., Mitchel, K.A., Peters, R.F., Tweed, M.F., Wallis, R.B. Recombinant desulphatohirudin (CGP 39393) anticoagulant and antithrombotic properties in vivo. Thromb Haemost. 1989;61:77–80. PubMed | Google Scholar • Just, M., Tripier, D., Seiffge, D. Antithrombotic effects of recombinant hirudin in different animal models. Haemostasis. 1991;21:80–87. PubMed | Google Scholar • Gray, E., Watton, J., Cesmeli, S., Barowcliffe, T.W., Thomas, D.P. Experimental studies on a recombinant hirudin. (CGP 39393)Thromb Haemost. 1991;65:355–359. PubMed | Google Scholar • Klöcking, H.-P., Markwardt, F. Influence of recombinant hirudin on the thrombogenicity of prothrombin complex concentrates. Pharmazie. 1989;44:341–342. Google Scholar • Raake, W., Klauser, R.J., Elling, H., Zeiller, P. Antithrombotic action of recombinant hirudin in a venous thrombosis model. Haemostasis. 1991;21:127–132. PubMed | Google Scholar • Bara, L., Bloch, M.F., Samama, M.M. A comparative study of recombinant hirudin and standard heparin in the Wessler model. Thromb Res. 1992;68:167–174. Abstract | Full Text PDF | PubMed | Scopus (8) | Google Scholar • Imura, Y., Stasse, J.M., Collen, D. Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model. J Pharmacol Exp Ther. 1992;261:895–898. PubMed | Google Scholar • Bucha, E., Nowak, G., Markwardt, F. Prevention of experimental coronary thrombosis by hirudin. Folia Haematol. 1988;115:52–58. Google Scholar • Markwardt, F. Prevention of coronary thrombosis by hirudin. in: J.Gy. Papp (Ed.) Cardiovascular Pharmacology '87 Budapest. Kiado, Budapest; 1987:449–456. Google Scholar • Heras, M., Chesebro, J.H., Penny, W.J., Bailey, K.R., Badimon, L., Fuster, V. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. in: Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation. 79. ; 1989:657–665. Google Scholar • Kaiser, B., Simon, A., Markwardt, F. Antithrombotic effects of recombinant hirudin in experimental angioplasty and intra vascular thrombolysis. Thromb Haemost. 1990;63:44–47. PubMed | Google Scholar • Rübsamen, K., Eschenfelder, V. Effect of recombinant hirudin (LU 52369) on reocclusion rates after thrombolysis in rabbits. Haemostasis. 1991;21:93–98. PubMed | Google Scholar • Zawilska, K., Zozulinska, M., Turowiecka, Z.M., Drobnik, L., Vinnazzer, H. The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIC) in rabbits. Thromb Res. 1993;69:315–320. Abstract | Full Text PDF | PubMed | Scopus (28) | Google Scholar • Sarembock, I.J., Gertz, S.D., Gimple, L.W., Owen, R.M., Powers, E.R., Roberts, W.C. Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation. 1991;84:432–435. Crossref | PubMed | Scopus (189) | Google Scholar • May, G.R., Paul, W., Crook, P., Butler, K.D., Page, C.P. The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit. Br J Pharmacol. 1992;106:133–138. Crossref | PubMed | Scopus (7) | Google Scholar • Rigel, D.F., Olson, R.W., Lappe, R.W. Comparison of hirudin and heparin as adjuncts to streptokinase thrombolysis in a canine model of coronary thrombosis. Circ Res. 1993;72:1091–1102. Crossref | PubMed | Scopus (36) | Google Scholar • Hoffmann, H., Siebeck, M., Spannagl, M., Weiss, M., Geiger, R., Jochum, M., Fritz, H. Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs. Am Rev Respir Dis. 1990;142:782–788.Crossref | PubMed | Scopus (40) | Google Scholar • Hauptmann, J., Brüggener, E. Influence of hirudin on the consumption of antithrombin III in experimental DIC. Folia Haematol. 1988;115:83–87. Google Scholar • Freund, M., Cazenave, J.P., Courtney, M., Degryse, E., Roitsch, C., Bernat, A., Delebassee, D., Defreyn, G., Maffrand, J.P. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue-factor in rats. Thromb Haemost. 1990;63:187–192. PubMed | Google Scholar • Nowak, G., Markwardt, F. Hirudin in disseminated intravascular coagulation. Haemostasis. 1991;2:142–148. Google Scholar • Markwardt, F. Experience with hirudin and other thrombin inhibitors in disseminated intravascular coagulation. in: L.C. Borris, M.R. Lassen, D.B. Bergquist (Eds.) The Traumatized Patient- With Special References to Systemic Complications. Roemer Graphic, Danmark; 1992:115–120. Google Scholar • Bucha, E., Markwardt, F., Nowak, G. Hirudin in haemodialysis. Thromb Res. 1990;60:445–455. Abstract | Full Text PDF | PubMed | Scopus (23) | Google Scholar • Markwardt, F., Nowak, G., Bucha, E. Hirudin as anticoagulant in experimental haemodialysis. Haemostasis. 1991;21:149–155. PubMed | Google Scholar • Walenga, J.M., Bakhos, M., Messmore, H.L., Fareed, J., Pifarre, R. The potential use of r-hirudin as an anticoagulant in cardiopulmonary bypass model. Blood Coagul Fibrinol. 1991;2:105–111. Crossref | PubMed | Google Scholar • Markwardt, F. Pharmacology of selective thrombin inhibitors. Nouv Rev Fr Hematol. 1988;30:161–163. PubMed | Google Scholar • Fareed, J., Walenga, J.M., Hoppensteadt, D., Iyer, L., Pifarre, R. Neutralization of recombinant hirudin. in: Some practical considerations. Semin Thromb Hemost. 17. ; 1991:137–144. Google Scholar •Brüggener, E., Walsmann, P., Markwardt, F. Neutralization of hirudin anticoagulant action by DIP-thrombin. Pharmazie. 1989;44:648–649. PubMed | Google Scholar • Walsmann, P. Untersuchungen zur Affinitätschromatographie von Hirudin an trägerfixiertem. Thrombin. Pharmazie. 1981;36:860–861. Google Scholar • Fareed, J., Walenga, J.M. Do we need to neutralize hirudin's anticoagulant effects to minimize bleeding?. Fed Proc. 1989;3:A 328. Google Scholar • Henschen, A., Markwardt, F., Walsmann, P. Identification by HPLC analysis of the unaltered forms of hirudin and desulfated hirudin after kidney passage (abstract). Thromb Res. 1987;7:37 (Suppl.). Abstract | Full Text PDF | Google Scholar • Zoldhelyi, P., Webster, M.W.I., Furster, V., Grill, D.E., Gaspar, D., Edwards, S.J., Cabot, C.F., Chesebro, J.H. Recombinant hirudin in patients with chronic, stable coronary artery disease. in: Safety, half-life, and effect on coagulation parameters. Circulation. 88. ; 1993:2015–2021. Google Scholar • Walenga, J.M., Pifarre, R., Hoppensteadt, D., Fareed, J. Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: Some objective considerations. Semin Thromb Hemost. 1989;15:316–333. Crossref | PubMed | Scopus (34) | Google Scholar • Nowak, G., Bucha, E., Gööck, Th., Thieler, H., Markwardt, F. Pharmacology of r-hirudin in renal impairment. Thromb Res. 1992;66:707–715. • Abstract | Full Text PDF | PubMed | Scopus (86) | Google Scholar • Vogel, G., Markwardt, F. Clinical use of hirudin. Folia haematol. 1988;115:113–118. Google Scholar • Breddin, H.K., Markwardt, F. Clinical experience with hirudin in disseminated intravascular coagulation. Thrombos Haemostas. 1903;69:1299. Google Scholar • van den Bos, A.A., Deckers, J.W., Heyndrickx, G.R., Laarman, G.J., Suryapranata, H., Zijlstra, F., Close, P., Rijnierse, J.J.M.M., Buller, H.R., Serruys, P.W. Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty. Circulation. 1993;88:2058–2066. Crossref | PubMed | Scopus (123) | Google Scholar • Neuhaus, K.L., von Essen, R., Niederer, W., Maeurer, W., Forycki, F., von Leitner, E., Tebbe, U., Appel, K-F., Mateblowski, M., Voigt, A., Zeymer, U. r-Hirudin and front-loaded alteplase in acute myocardial infarction: Results of the HIT (Hirudin for Improvement of Thrombolysis) study. Eur Heart J. 1993;14:106. Crossref | PubMed | Scopus (17) | Google Scholar • Cannon, C.P., McCabe, C.H., Henry, T.D., Rogers, W.J., Schweiger, M., Gibson, R.S., Anderson, J.L., Williams, D.O., Braunwald, E. Hirudin reduces reocclusion compared to heparin following thrombolysis in acute myocardial infarction: results of the TIMI 5 trial. J Am Coll Cardiol. 1993;21:136A (abstract). Google Scholar • Hauptmann, J., Markwardt, F. Pharmacologic aspects of the development of selective synthetic thrombin inhibitors as anticoagulants. Semin Thromb Hemost. 1992;18:200–217. Crossref | PubMed | Scopus (52) | Google Scholar • Maraganore, J.M., Bourdon, P., Jablonski, J., Ramachandran, K.L., Fenton, J.W. II. Design and characterization of hirulogs: A novel class of bivalent peptide inhibitors of thrombin. Biochemistry. 1990;29:7095–7101. Crossref | PubMed | Scopus (409) | Google Scholar • Markwardt, F. Coagulation inhibitors of blood-sucking animals-A new line of developing antithrombotic drugs. Pharmazie. 1994;49:202–212. PubMed | Google Scholar

Najwcześniejsze publikacje z przełomu IXX i XX wieku

Haycraft, J.B. Über die Einwirkung eines Sekretes des officinellen Blutegels auf die Gerinnbarkeit des Bluts. Naunyn Schmiedeberg's Arch Exp Pathol Pharmak. 1894;18:209–217. Crossref | Scopus (41) | Google Scholar • Franz, F. Über den die Blutgerinnung aufhebenden Bestandteil des medizinischen Blutegels. Naunyn Schmiedeberg's Arch Exp Pathol Pharmak. 1903;49:342–357. Crossref | Scopus (11) | Google Scholar • Jacobi, Y. Über Hirudin. Deutsch Med Wochenschr. 1904;30:1786–1787. Google Scholar

CME Świebodzice

© 2018. Proudly created with CME

Konsultacja naukowa: dr n. med. Arkadiusz Konieczny

  • Profil
  • Profil Konsultanta Naukowego